Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh
· Delayed Price · Currency is BDT 13.60
-0.20 (-1.45%)
At close: Dec 4, 2025
Advent Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | 66.87 | 83.99 | 98.64 | 97.53 | 113.59 | Upgrade
|
| Depreciation & Amortization | 63.05 | 66.51 | 59.18 | 42.27 | 38.75 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 29.61 | 0.02 | - | 0.39 | Upgrade
|
| Other Operating Activities | 28.53 | 29.68 | 38.47 | 38.36 | 24.42 | Upgrade
|
| Change in Accounts Receivable | -45.71 | -16.32 | -10.32 | -2.15 | 4.21 | Upgrade
|
| Change in Inventory | 1.07 | 12.51 | 0.78 | -5.12 | -7.53 | Upgrade
|
| Change in Accounts Payable | 0.44 | -10.96 | 10.83 | 1.08 | -1.31 | Upgrade
|
| Change in Other Net Operating Assets | 0.49 | -19.89 | 7.7 | 7.6 | 7.86 | Upgrade
|
| Operating Cash Flow | 114.74 | 175.13 | 205.3 | 179.57 | 180.38 | Upgrade
|
| Operating Cash Flow Growth | -34.48% | -14.69% | 14.33% | -0.45% | 6.05% | Upgrade
|
| Capital Expenditures | -94.18 | -162.06 | -202.73 | -191.13 | -184.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 2.7 | 0.68 | - | 0.23 | Upgrade
|
| Investment in Securities | - | - | - | 40 | - | Upgrade
|
| Investing Cash Flow | -94.18 | -159.36 | -202.06 | -151.13 | -183.83 | Upgrade
|
| Short-Term Debt Issued | - | 5.01 | 11.72 | 6.44 | 13.47 | Upgrade
|
| Total Debt Issued | - | 5.01 | 11.72 | 6.44 | 13.47 | Upgrade
|
| Short-Term Debt Repaid | -1.33 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.64 | -0.59 | -4.04 | -4.2 | -2.59 | Upgrade
|
| Total Debt Repaid | -1.97 | -0.59 | -4.04 | -4.2 | -2.59 | Upgrade
|
| Net Debt Issued (Repaid) | -1.97 | 4.42 | 7.68 | 2.25 | 10.88 | Upgrade
|
| Common Dividends Paid | -14.75 | -8.2 | -8.81 | -22.22 | -8.08 | Upgrade
|
| Other Financing Activities | -6.04 | -9.1 | -5.35 | -6.84 | -3.01 | Upgrade
|
| Financing Cash Flow | -22.76 | -12.88 | -6.48 | -26.82 | -0.21 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | 0 | - | - | - | Upgrade
|
| Net Cash Flow | -2.2 | 2.89 | -3.24 | 1.63 | -3.65 | Upgrade
|
| Free Cash Flow | 20.56 | 13.08 | 2.56 | -11.56 | -3.67 | Upgrade
|
| Free Cash Flow Growth | 57.25% | 409.89% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 4.11% | 2.29% | 0.46% | -2.18% | -0.73% | Upgrade
|
| Free Cash Flow Per Share | 0.22 | 0.14 | 0.03 | -0.12 | -0.04 | Upgrade
|
| Cash Interest Paid | 6.04 | 9.1 | 5.35 | 6.83 | 3.01 | Upgrade
|
| Cash Income Tax Paid | 0.24 | 2.86 | 3.08 | 2.36 | 3.9 | Upgrade
|
| Levered Free Cash Flow | -20.56 | -36.41 | -44.03 | -68.27 | -56.36 | Upgrade
|
| Unlevered Free Cash Flow | -14.84 | -31.35 | -39.89 | -65.7 | -53.3 | Upgrade
|
| Change in Working Capital | -43.71 | -34.66 | 8.99 | 1.41 | 3.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.